Insider Transactions in Q1 2021 at Biomarin Pharmaceutical Inc (BMRN)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 30
2021
|
Jeffrey Robert Ajer EVP, Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
1,652
-2.69%
|
$122,248
$74.79 P/Share
|
|
Mar 24
2021
|
Jeffrey Robert Ajer EVP, Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
1,181
-1.89%
|
$89,756
$76.3 P/Share
|
|
Mar 22
2021
|
Jeffrey Robert Ajer EVP, Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,513
-2.36%
|
$118,014
$78.52 P/Share
|
|
Mar 22
2021
|
Jean Jacques Bienaime Director |
SELL
Payment of exercise price or tax liability
|
Direct |
5,519
-1.79%
|
$430,482
$78.52 P/Share
|
|
Mar 22
2021
|
George Eric Davis EVP, Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,391
-1.99%
|
$108,498
$78.52 P/Share
|
|
Mar 22
2021
|
Henry J Fuchs President, Worldwide R&D |
SELL
Payment of exercise price or tax liability
|
Direct |
2,454
-2.26%
|
$191,412
$78.52 P/Share
|
|
Mar 22
2021
|
Brian Mueller EVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
516
-1.39%
|
$40,248
$78.52 P/Share
|
|
Mar 18
2021
|
Jeffrey Robert Ajer EVP, Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
1,308
-2.0%
|
$100,716
$77.99 P/Share
|
|
Mar 16
2021
|
Andrea Acosta GVP, Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
379
-2.05%
|
$29,183
$77.21 P/Share
|
|
Mar 16
2021
|
Jean Jacques Bienaime Director |
SELL
Payment of exercise price or tax liability
|
Direct |
5,559
-1.77%
|
$428,043
$77.21 P/Share
|
|
Mar 16
2021
|
Jeffrey Robert Ajer EVP, Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,287
-1.93%
|
$99,099
$77.21 P/Share
|
|
Mar 16
2021
|
Henry J Fuchs President, Worldwide R&D |
SELL
Payment of exercise price or tax liability
|
Direct |
2,259
-2.04%
|
$173,943
$77.21 P/Share
|
|
Mar 16
2021
|
George Eric Davis EVP, Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,252
-1.76%
|
$96,404
$77.21 P/Share
|
|
Mar 16
2021
|
Brian Mueller EVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
582
-1.54%
|
$44,814
$77.21 P/Share
|
|
Mar 15
2021
|
Andrea Acosta GVP, Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
553
-2.9%
|
$43,134
$78.39 P/Share
|
|
Mar 15
2021
|
Andrea Acosta GVP, Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,290
+18.37%
|
-
|
|
Mar 15
2021
|
Jean Jacques Bienaime Director |
SELL
Payment of exercise price or tax liability
|
Direct |
23,426
-6.95%
|
$1,827,228
$78.39 P/Share
|
|
Mar 15
2021
|
Jean Jacques Bienaime Director |
BUY
Grant, award, or other acquisition
|
Direct |
41,350
+10.93%
|
-
|
|
Mar 15
2021
|
Jeffrey Robert Ajer EVP, Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,273
-7.32%
|
$411,294
$78.39 P/Share
|
|
Mar 15
2021
|
Jeffrey Robert Ajer EVP, Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,720
+12.96%
|
-
|
|
Mar 15
2021
|
Henry J Fuchs President, Worldwide R&D |
SELL
Payment of exercise price or tax liability
|
Direct |
7,460
-6.31%
|
$581,880
$78.39 P/Share
|
|
Mar 15
2021
|
Henry J Fuchs President, Worldwide R&D |
BUY
Grant, award, or other acquisition
|
Direct |
15,320
+11.46%
|
-
|
|
Mar 15
2021
|
George Eric Davis EVP, Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,014
-6.59%
|
$391,092
$78.39 P/Share
|
|
Mar 15
2021
|
George Eric Davis EVP, Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,420
+12.04%
|
-
|
|
Mar 15
2021
|
Brian Mueller EVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
994
-2.56%
|
$77,532
$78.39 P/Share
|
|
Mar 15
2021
|
Brian Mueller EVP, Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,110
+20.67%
|
-
|
|
Mar 15
2021
|
Charles Greg Guyer EVP, Chief Technical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,420
+18.65%
|
-
|
|
Mar 12
2021
|
Jean Jacques Bienaime Director |
SELL
Open market or private sale
|
Direct |
7,000
-2.31%
|
$539,000
$77.1 P/Share
|
|
Mar 12
2021
|
Jean Jacques Bienaime Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,000
+2.26%
|
$182,000
$26.49 P/Share
|
|
Mar 11
2021
|
Jean Jacques Bienaime Director |
SELL
Open market or private sale
|
Direct |
7,000
-2.31%
|
$539,000
$77.68 P/Share
|
|
Mar 11
2021
|
Jean Jacques Bienaime Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,000
+2.26%
|
$182,000
$26.49 P/Share
|
|
Mar 05
2021
|
Michael G Grey Director |
SELL
Open market or private sale
|
Direct |
5,000
-10.45%
|
$380,000
$76.28 P/Share
|
|
Mar 05
2021
|
Michael G Grey Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+9.46%
|
$130,000
$26.49 P/Share
|
|
Mar 04
2021
|
Jean Jacques Bienaime Director |
BUY
Small Acquisition
|
Direct |
100
+0.03%
|
$7,700
$77.94 P/Share
|
|
Feb 19
2021
|
Jean Jacques Bienaime Director |
SELL
Open market or private sale
|
Direct |
7,000
-2.31%
|
$581,000
$83.58 P/Share
|
|
Feb 19
2021
|
Jean Jacques Bienaime Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,000
+2.26%
|
$182,000
$26.49 P/Share
|
|
Feb 18
2021
|
Jean Jacques Bienaime Director |
SELL
Open market or private sale
|
Direct |
7,000
-2.31%
|
$595,000
$85.08 P/Share
|
|
Feb 18
2021
|
Jean Jacques Bienaime Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,000
+2.26%
|
$182,000
$26.49 P/Share
|
|
Feb 17
2021
|
Maykin Ho Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,350
+50.0%
|
-
|
|
Feb 17
2021
|
Jean Jacques Bienaime Director |
SELL
Open market or private sale
|
Direct |
8,000
-2.64%
|
$672,000
$84.54 P/Share
|
|
Feb 17
2021
|
Jean Jacques Bienaime Director |
BUY
Exercise of conversion of derivative security
|
Direct |
8,000
+2.57%
|
$208,000
$26.49 P/Share
|
|
Feb 16
2021
|
V Bryan Lawlis Director |
SELL
Open market or private sale
|
Direct |
7,500
-28.46%
|
$652,500
$87.41 P/Share
|
|
Feb 16
2021
|
V Bryan Lawlis Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+22.16%
|
$195,000
$26.49 P/Share
|
|
Feb 03
2021
|
Brian Mueller EVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,071
-3.6%
|
$87,822
$82.82 P/Share
|
|
Jan 29
2021
|
Jean Jacques Bienaime Director |
SELL
Open market or private sale
|
Direct |
8,334
-2.74%
|
$683,388
$82.67 P/Share
|
|
Jan 29
2021
|
Jean Jacques Bienaime Director |
BUY
Exercise of conversion of derivative security
|
Direct |
8,334
+2.67%
|
$216,684
$26.49 P/Share
|
|
Jan 28
2021
|
Jean Jacques Bienaime Director |
SELL
Open market or private sale
|
Direct |
8,333
-2.74%
|
$683,306
$82.91 P/Share
|
|
Jan 28
2021
|
Jean Jacques Bienaime Director |
BUY
Exercise of conversion of derivative security
|
Direct |
8,333
+2.67%
|
$216,658
$26.49 P/Share
|
|
Jan 27
2021
|
Jean Jacques Bienaime Director |
SELL
Open market or private sale
|
Direct |
8,333
-2.74%
|
$708,305
$85.49 P/Share
|
|
Jan 27
2021
|
Jean Jacques Bienaime Director |
BUY
Exercise of conversion of derivative security
|
Direct |
8,333
+2.67%
|
$216,658
$26.49 P/Share
|